helio glow kite LLC

17 madison court
wallkill, new york 12589

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 19, 2013

NYS DOS ID#
4361630

County
ORANGE

Jurisdiction
NEW YORK

Registered Agent
JAMES FILLINI JR.
17 MADISON COURT
WALLKILL, NEW YORK, 12589

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - HELIO GLOW KITE LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Berkeley’s Kite Festival a chance to enjoy the outdoors
    By Sarah Ravani - Saturday Jul 29, 2017

    Lawrence McClarty started his day early Saturday. He loaded his car with kites and folding chairs, filled his stomach with waffles from a nearby diner and arrived by 7 a.m. at the Berkeley Marina. The 57-year-old Oakland resident’s eagle kite was the first to pierce the clouds. Not long after, McClarty was joined by hundreds of families at the Berkeley Kite Festival, a two-day event that draws thousands of people, as children watched their parents fly kites, grabbing ahold of the handle once the kites soared above them. McClarty made his debut at the festival two years ago without any experience flying kites. He started with a $20 kite.

    Source: SFGATE.com: Bay Area News
  • Gilead to Buy Kite Pharma for Roughly $11 Billion
    Monday Aug 28, 2017

    Gilead Sciences has agreed to pay about $11 billion for Kite Pharma and its promising new technology for harnessing the body’s immune system to fight cancer.

    Source: The Wall Street Journal: U.S. Business
  • Gilead Gets FDA Approval for New Cancer Therapy
    Wednesday Oct 18, 2017

    Gilead Sciences’ $11 billion bet on Kite Pharma is poised to pay off, with the approval of Kite’s flagship cell-therapy treatment for advanced lymphoma patients.

    Source: The Wall Street Journal: U.S. Business